Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination

Sharon Walmsley,Majid Nabipoor,Freda Qi,Leif Erik Lovblom,Rizani Ravindran,Karen Colwill,Roya Monica Dayam,Tulunay R. Tursun,Amanda Silva,Anne-Claude Gingras,on behalf of the STOPCoV Team

DOI: https://doi.org/10.3390/vaccines12060564

2024-05-23

Vaccines

Abstract:We determined neutralizing antibody levels to the ancestral Wuhan SARS-CoV-2 strain and three Omicron variants, namely BA.5, XBB.1.5, and EG.5, in a heavily vaccinated cohort of 178 adults 15–19 months after the initial vaccine series and prospectively after 4 months. Although all participants had detectable neutralizing antibodies to Wuhan, the proportion with detectable neutralizing antibodies to the Omicron variants was decreased, and the levels were lower. Individuals with hybrid immunity at the baseline visit and those receiving the Original/Omicron bivalent vaccine between the two sampling times demonstrated increased neutralizing antibodies to all strains. Both a higher baseline neutralizing antibody titer to Omicron BA.5 and hybrid immunity were associated with protection against a breakthrough SARS-CoV-2 infection during a 4-month period of follow up during the Omicron BA.5 wave. Neither were associated with protection from a breakthrough infection at 10 months follow up. Receipt of an Original/Omicron BA.4/5 vaccine was associated with protection from a breakthrough infection at both 4 and 10 months follow up. This work demonstrates neutralizing antibody escape with the emerging Omicron variants and supports the use of additional vaccine doses with components that match circulating SARS-CoV-2 variants. A threshold value for neutralizing antibodies for protection against reinfection cannot be determined.

immunology,medicine, research & experimental

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the changes in neutralizing antibody levels against the original SARS - CoV - 2 Wuhan strain and Omicron variants (including BA.5, XBB.1.5 and EG.5) in highly vaccinated populations, as well as the effects of hybrid immunity (i.e., the immune state combining natural infection and vaccination) and original/Omicron bivalent vaccination on these neutralizing antibody levels. Specifically, the study focuses on the following points:

1. **Changes in neutralizing antibody levels**: The changes in neutralizing antibody levels in 178 adults within 15 - 19 months after the initial vaccine series and within the subsequent 4 months were studied. Although all participants had detectable neutralizing antibodies against the Wuhan strain, the proportion and level of neutralizing antibodies against Omicron variants decreased.

2. **Effect of hybrid immunity**: It was studied whether individuals with hybrid immunity at the baseline visit and those who received the original/Omicron bivalent vaccine during this period had higher neutralizing antibody levels.

3. **Protective effect of breakthrough infection**: It was studied whether higher Omicron BA.5 neutralizing antibody titers and hybrid immunity at the baseline visit could protect participants from breakthrough infection within 4 months during the Omicron BA.5 epidemic. In addition, the protective effects of these factors within the 10 - month follow - up period were also evaluated.

4. **Effect of vaccine booster shots**: It was studied whether receiving the original/Omicron BA.4/5 vaccine booster shot could provide better protection against breakthrough infection within 4 - month and 10 - month follow - up periods.

Through these studies, the paper aims to understand the effects of different immune states and vaccine strategies on neutralizing antibody levels and the risk of breakthrough infection, thereby providing a scientific basis for future vaccination strategies.